LifeStance Health Group Future Growth
Future criteria checks 1/6
LifeStance Health Group is forecast to grow earnings and revenue by 45.2% and 12.8% per annum respectively. EPS is expected to grow by 44.2% per annum. Return on equity is forecast to be -3.3% in 3 years.
Key information
45.2%
Earnings growth rate
44.2%
EPS growth rate
Healthcare earnings growth | 15.8% |
Revenue growth rate | 12.8% |
Future return on equity | -3.3% |
Analyst coverage | Good |
Last updated | 13 Mar 2024 |
Recent future growth updates
Recent updates
Calculating The Intrinsic Value Of LifeStance Health Group, Inc. (NASDAQ:LFST)
Mar 23LifeStance Health Group, Inc. (NASDAQ:LFST) Released Earnings Last Week And Analysts Lifted Their Price Target To US$8.50
Mar 02LifeStance Q4 Earnings Review: Monetizing Mental Health Virtually Is Problematic
Feb 29Does LifeStance Health Group (NASDAQ:LFST) Have A Healthy Balance Sheet?
Feb 28LifeStance Health Group, Inc.'s (NASDAQ:LFST) P/S Still Appears To Be Reasonable
Jan 23What Is LifeStance Health Group, Inc.'s (NASDAQ:LFST) Share Price Doing?
Jul 08Is LifeStance Health Group, Inc. (NASDAQ:LFST) Expensive For A Reason? A Look At Its Intrinsic Value
May 09LifeStance Health appoints new key person
Sep 08Is LifeStance Health Group, Inc. (NASDAQ:LFST) Trading At A 48% Discount?
Sep 05LifeStance Health Reiterates Guidance Amid High Operating Losses
Jul 19Health Care falls 2.8% in June, Nutex, CureVac biggest losers
Jul 01An Intrinsic Calculation For LifeStance Health Group, Inc. (NASDAQ:LFST) Suggests It's 47% Undervalued
May 26LifeStance Health Group: Real Issues
Apr 28Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 1,566 | -48 | 57 | 117 | 3 |
12/31/2025 | 1,382 | -76 | 39 | 84 | 7 |
12/31/2024 | 1,219 | -104 | 11 | 48 | 8 |
12/31/2023 | 1,056 | -186 | -57 | -17 | N/A |
9/30/2023 | 1,004 | -188 | -37 | 2 | N/A |
6/30/2023 | 959 | -164 | -11 | 33 | N/A |
3/31/2023 | 909 | -187 | -17 | 42 | N/A |
12/31/2022 | 860 | -216 | -26 | 53 | N/A |
9/30/2022 | 820 | -277 | -60 | 48 | N/A |
6/30/2022 | 776 | -360 | -89 | 28 | N/A |
3/31/2022 | 727 | -361 | -109 | 3 | N/A |
12/31/2021 | 668 | -344 | -85 | 9 | N/A |
9/30/2021 | 596 | -515 | -83 | -17 | N/A |
6/30/2021 | 524 | -397 | -44 | 8 | N/A |
3/31/2021 | 447 | -331 | -42 | -1 | N/A |
12/31/2020 | 377 | -286 | -47 | -9 | N/A |
12/31/2019 | 213 | -59 | 3 | 17 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: LFST is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: LFST is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: LFST is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: LFST's revenue (12.8% per year) is forecast to grow faster than the US market (8% per year).
High Growth Revenue: LFST's revenue (12.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: LFST is forecast to be unprofitable in 3 years.